Retatrutide is gaining attention for its weight-loss potential, but new clinical trials suggest it may also improve sleep ...

The same drugs easing sleep apnea may be drying out your mouth and eroding your teeth.

Eli Lilly's retatrutide cut breathing interruptions and drove significant weight loss in sleep apnea patients, as well as ...

A scoping review of 11 studies finds associations between obstructive sleep apnea and long COVID that vary in direction and ...

The obstructive sleep apnea competitive landscape report delivers important insights into approved as well as ongoing research on 22+ pipeline obstructive sleep apnea drugs, clinical strategies, ...

Sleep apnea treatment, whether it's with a CPAP, a BiPAP, or an oral appliance, is an important part of achieving better, more refreshing sleep when you have obstructive sleep apnea (OSA). But even ...

A randomized controlled trial found that eight weeks of home-based, remotely supervised pranayama breathing training ...

Two Phase 3 trials found that retatrutide reduced sleep apnea breathing events in adults with and without type 2 diabetes.

Eli Lilly’s experimental weight-loss drug retatrutide reduced sleep apnea symptoms by over 50% in 68% of trial participants.

Obstructive sleep apnea (OSA) is typically measured on a scale called the apnea-hypopnea index (AHI), which determines how many times you stop breathing (apnea) and how often your breathing is ...

Incretin-based therapies, particularly tirzepatide and liraglutide, can reduce obstructive sleep apnea severity in adults with obesity while improving weight and some cardiometabolic risk factors.